Identification of microRNA-451a as a Novel Circulating Biomarker for Colorectal Cancer Diagnosis

Abstract EN

Background.

Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide.

Successful treatment of CRC relies on accurate early diagnosis, which is currently a challenge due to its complexity and personalized pathologies.

Thus, novel molecular biomarkers are needed for early CRC detection.

Methods.

Gene and microRNA microarray profiling of CRC tissues and miRNA-seq data were analyzed.

Candidate microRNA biomarkers were predicted using both CRC-specific network and miRNA-BD tool.

Validation analyses were carried out to interrogate the identified candidate CRC biomarkers.

Results.

We identified miR-451a as a potential early CRC biomarker circulating in patient’s serum.

The dysregulation of miR-451a was revealed both in primary tumors and in patients’ sera.

Downstream analysis validated the tumor suppressor role of miR-451a and high sensitivity of miR-451a in CRC patients, further confirming its potential role as CRC circulation biomarker.

Conclusion.

The miR-451a is a potential circulating biomarker for early CRC diagnosis.